 <h1>Penicillamine Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of penicillamine include:</b> cheilosis, epigastric pain, glossitis, oral mucosa ulcer, ageusia, and dysgeusia. <b>Other side effects include:</b> thrombocytopenia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to penicillamine: oral capsule, oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Capsule)</p><p>Physicians planning to use penicillamine should thoroughly familiarize themselves with its toxicity, special dosage considerations, and therapeutic benefits. Penicillamine should never be used casually. Each patient should remain constantly under the close supervision of the physician. Patients should be warned to report promptly any symptoms suggesting toxicity.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, penicillamine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>Check with your doctor as soon as possible if any of the following side effects occur while taking penicillamine:</p><p>
<i>More common</i>
</p><ul>
<li>Fever</li>
<li>joint pain</li>
<li> lesions on the face, neck, scalp, and/or trunk</li>
<li> skin rash, hives, or itching</li>
<li>swollen and/or painful glands</li>
<li>ulcers, sores, or white spots on lips or in mouth</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Bloody or cloudy urine</li>
<li>shortness of breath, troubled breathing, tightness in chest, or wheezing</li>
<li>sore throat and fever with or without chills</li>
<li> swelling of face, feet, or lower legs</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>weight gain</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Abdominal or stomach pain (severe)</li>
<li> blisters on skin</li>
<li>bloody or black, tarry stools</li>
<li>chest pain</li>
<li>coughing or hoarseness</li>
<li>dark urine</li>
<li>difficulty in breathing, chewing, talking, or swallowing</li>
<li>eye pain, blurred or double vision, or any change in vision</li>
<li>general feeling of discomfort or illness or weakness</li>
<li>lower back or side pain</li>
<li>muscle weakness</li>
<li>painful or difficult urination</li>
<li>pale stools</li>
<li>pinpoint red spots on skin</li>
<li>redness, tenderness, itching, burning, or peeling of skin</li>
<li>red or irritated eyes</li>
<li>red, thick, or scaly skin</li>
<li>ringing or buzzing in the ears</li>
<li>spitting blood</li>
<li>yellow eyes or skin </li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of penicillamine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Diarrhea</li>
<li>lessening or loss of sense of taste</li>
<li>loss of appetite</li>
<li> nausea or vomiting</li>
<li>stomach pain (mild)</li>
</ul><p>
<!-- end oral capsule, oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to penicillamine: oral capsule, oral tablet</i></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Blunting, diminution, or total loss of taste (12%) </p>
<p><b>Frequency not reported</b>: Headache, dizziness, deterioration of neurological symptoms of Wilson's disease (dystonia, rigidity, tremor, dysarthria) following introduction of therapy in patients treated for this condition (this may be a consequence of mobilization and redistribution of copper from the liver to the brain), arthralgia, tinnitus, peripheral sensory and motor neuropathies (including polyradiculoneuropathy, i.e., Guillain-Barre Syndrome)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Epigastric pain (17%), nausea (17%), vomiting (17%), diarrhea (17%)</p>
<p><b>Rare</b> (0.01% to 0.1%): Mouth ulceration, stomatitis, glossitis </p>
<p><b>Frequency not reported</b>: Pancreatitis, reactivated peptic ulcer<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Thrombocytopenia, leukopenia</p>
<p><b>Frequency not reported</b>: Neutropenia (usually reversible), agranulocytosis (sometimes fatal), aplastic anemia (sometimes fatal), hemolytic anemia, lymphadenopathy, thrombotic thrombocytopenic purpura, red cell aplasia, monocytosis, leukocytosis, eosinophilia, thrombocytosis<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Proteinuria</p>
<p><b>Rare</b> (less than 0.1%): Hematuria, renal vasculitis </p>
<p><b>Frequency not reported</b>: Nephrotic syndrome, glomerulonephritis, Goodpasture's syndrome<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Rare</b> (less than 0.1%): Polymyositis, dermatomyositis </p>
<p><b>Frequency not reported</b>: Lupus erythematosus, myasthenia gravis, rheumatoid arthritis, septic arthritis (in patients with rheumatoid arthritis), muscular weakness<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash (early and/or later in therapy), pruritus</p>
<p><b>Rare</b> (less than 0.1%): Alopecia, pseudoxanthoma elasticum, elastosis perforans, skin laxity, lichen planus </p>
<p><b>Frequency not reported</b>: Urticaria, epidermolysis bullosa, exfoliative dermatitis, dermopathy, dermatomyositis, pemphigus, Stevens-Johnson syndrome<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Rare</b> (less than 0.1%): Bronchial asthma </p>
<p><b>Frequency not reported</b>: Pulmonary hemorrhage, dyspnea, pleural effusion, alveolitis, pulmonary fibrosis, bronchiolitis, pneumonitis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Deafness, fever, the chelating action of the drug may cause increased excretion of other heavy metals (in addition to copper) such as zinc, mercury, and lead<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Rare</b> (less than 0.1%): Breast enlargement<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Rare</b> (less than 0.1%): Intrahepatic cholestasis, toxic hepatitis </p>
<p><b>Frequency not reported</b>: Cholestatic jaundice, hepatic dysfunction, pancreatitis, increased serum alkaline phosphatase, increased lactic dehydrogenase, positive cephalin flocculation test, positive thymol turbidity test<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Abnormal vision, optic neuritis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Rare</b> (less than 0.1%): Thrombophlebitis<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very rare</b> (less than 0.01%): Thyroiditis<sup>[Ref]</sup></p><h3>General</h3><p>Both the frequency and severity of many side effects are dose related and vary according to the disease being treated.  Initiating therapy at lower doses and titrating up helps to attenuate some side effects.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Allergic reactions including hypersensitivity<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Confusion<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Cuprimine (penicillamine)." Merck &amp; Co, Inc, West Point, PA. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about penicillamine</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>2 Reviews</li>
<li>Drug class: antirheumatics</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Penicillamine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Cuprimine, Depen, D-Penamine</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Wilson's Disease</li>
<li>Cystinuria</li>
<li>Rheumatoid Arthritis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to penicillamine: oral capsule, oral tablet</i></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Blunting, diminution, or total loss of taste (12%) </p><p><b>Frequency not reported</b>: Headache, dizziness, deterioration of neurological symptoms of Wilson's disease (dystonia, rigidity, tremor, dysarthria) following introduction of therapy in patients treated for this condition (this may be a consequence of mobilization and redistribution of copper from the liver to the brain), arthralgia, tinnitus, peripheral sensory and motor neuropathies (including polyradiculoneuropathy, i.e., Guillain-Barre Syndrome)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Epigastric pain (17%), nausea (17%), vomiting (17%), diarrhea (17%)</p><p><b>Rare</b> (0.01% to 0.1%): Mouth ulceration, stomatitis, glossitis </p><p><b>Frequency not reported</b>: Pancreatitis, reactivated peptic ulcer<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Thrombocytopenia, leukopenia</p><p><b>Frequency not reported</b>: Neutropenia (usually reversible), agranulocytosis (sometimes fatal), aplastic anemia (sometimes fatal), hemolytic anemia, lymphadenopathy, thrombotic thrombocytopenic purpura, red cell aplasia, monocytosis, leukocytosis, eosinophilia, thrombocytosis<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Proteinuria</p><p><b>Rare</b> (less than 0.1%): Hematuria, renal vasculitis </p><p><b>Frequency not reported</b>: Nephrotic syndrome, glomerulonephritis, Goodpasture's syndrome<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Rare</b> (less than 0.1%): Polymyositis, dermatomyositis </p><p><b>Frequency not reported</b>: Lupus erythematosus, myasthenia gravis, rheumatoid arthritis, septic arthritis (in patients with rheumatoid arthritis), muscular weakness<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash (early and/or later in therapy), pruritus</p><p><b>Rare</b> (less than 0.1%): Alopecia, pseudoxanthoma elasticum, elastosis perforans, skin laxity, lichen planus </p><p><b>Frequency not reported</b>: Urticaria, epidermolysis bullosa, exfoliative dermatitis, dermopathy, dermatomyositis, pemphigus, Stevens-Johnson syndrome<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Rare</b> (less than 0.1%): Bronchial asthma </p><p><b>Frequency not reported</b>: Pulmonary hemorrhage, dyspnea, pleural effusion, alveolitis, pulmonary fibrosis, bronchiolitis, pneumonitis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Deafness, fever, the chelating action of the drug may cause increased excretion of other heavy metals (in addition to copper) such as zinc, mercury, and lead<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Rare</b> (less than 0.1%): Breast enlargement<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Rare</b> (less than 0.1%): Intrahepatic cholestasis, toxic hepatitis </p><p><b>Frequency not reported</b>: Cholestatic jaundice, hepatic dysfunction, pancreatitis, increased serum alkaline phosphatase, increased lactic dehydrogenase, positive cephalin flocculation test, positive thymol turbidity test<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Abnormal vision, optic neuritis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Rare</b> (less than 0.1%): Thrombophlebitis<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very rare</b> (less than 0.01%): Thyroiditis<sup>[Ref]</sup></p><h3>General</h3><p>Both the frequency and severity of many side effects are dose related and vary according to the disease being treated.  Initiating therapy at lower doses and titrating up helps to attenuate some side effects.<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (less than 0.1%): Allergic reactions including hypersensitivity<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Confusion<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Cuprimine (penicillamine)." Merck &amp; Co, Inc, West Point, PA. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about penicillamine</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>2 Reviews</li>
<li>Drug class: antirheumatics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Penicillamine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +3 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Wilson's Disease</li>
<li>Cystinuria</li>
<li>Rheumatoid Arthritis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>